BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27524902)

  • 1. Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population.
    Morales-Marín ME; Genis-Mendoza AD; Tovilla-Zarate CA; Lanzagorta N; Escamilla M; Nicolini H
    Neuropsychiatr Dis Treat; 2016; 12():1843-8. PubMed ID: 27524902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between the Brain-derived Neurotrophic Factor Val66Met Polymorphism and Overweight/Obesity in Pediatric Population.
    Martínez-Ezquerro JD; Rendón-Macías ME; Zamora-Mendoza G; Serrano-Meneses J; Rosales-Rodríguez B; Escalante-Bautista D; Rodríguez-Cruz M; Sánchez-González R; Arellano-Pineda Y; López-Alarcón M; Zampedri MC; Rosas-Vargas H
    Arch Med Res; 2017 Oct; 48(7):599-608. PubMed ID: 29506764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.
    González-Castro TB; Nicolini H; Lanzagorta N; López-Narváez L; Genis A; Pool García S; Tovilla-Zárate CA
    Bipolar Disord; 2015 Feb; 17(1):27-38. PubMed ID: 25041243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of BDNF Val66Met polymorphism on cognition in Bipolar Disorder: A review: Special Section on "Translational and Neuroscience Studies in Affective Disorders" Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.
    Mandolini GM; Lazzaretti M; Pigoni A; Delvecchio G; Soares JC; Brambilla P
    J Affect Disord; 2019 Jan; 243():552-558. PubMed ID: 30078664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of
    Paul P; Nadella RK; Sen S; Ithal D; Mahadevan J; Reddy Y C J; Jain S; Purushottam M; Viswanath B
    J Psychopharmacol; 2021 Dec; 35(12):1510-1516. PubMed ID: 34311608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.
    Kanazawa T; Glatt SJ; Kia-Keating B; Yoneda H; Tsuang MT
    Psychiatr Genet; 2007 Jun; 17(3):165-70. PubMed ID: 17417060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF Val66Met genetic variation and its plasma level in patients with morbid obesity: A case-control study.
    Zamani M; Hosseini SV; Behrouj H; Erfani M; Dastghaib S; Ahmadi M; Shamsdin SA; Mokarram P
    Gene; 2019 Jul; 705():51-54. PubMed ID: 31004714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
    Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
    J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder.
    De Luca V; Strauss J; Semeralul M; Huang S; Li PP; Warsh JJ; Kennedy JL; Wong AH
    Neurosci Lett; 2008 Aug; 441(2):229-32. PubMed ID: 18606495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of Brain Derived Neurotrophic Factor (BDNF) Val66Met CpG site is associated with early onset bipolar disorder.
    Nassan M; Veldic M; Winham S; Frye MA; Larrabee B; Colby C; Biernacka J; Bellia F; Pucci M; Terenius L; Vukojevic V; D'Addario C
    J Affect Disord; 2020 Apr; 267():96-102. PubMed ID: 32063579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between BDNF Val66Met polymorphism and generalized anxiety disorder and clinical characteristics in a Mexican population: A case-control study.
    González-Castro TB; Pool-García S; Tovilla-Zárate CA; Juárez-Rojop IE; López-Narváez ML; Frésan A; Genis-Mendoza AD; Pérez-Hernández N; Nicolini H
    Medicine (Baltimore); 2019 Mar; 98(11):e14838. PubMed ID: 30882674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder.
    Zeni CP; Tramontina S; Aguiar BW; Salatino-Oliveira A; Pheula GF; Sharma A; Stertz L; Moreira Maia CR; Hutz M; Kapczinski FP; Rohde LA
    Acta Psychiatr Scand; 2016 Sep; 134(3):268-74. PubMed ID: 27209073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study of anxiety symptoms, family dysfunction, and the brain-derived neurotrophic factor (BDNF) Val66Met genotype in offspring of parents with bipolar disorder.
    Park MH; Chang KD; Hallmayer J; Howe ME; Kim E; Hong SC; Singh MK
    J Psychiatr Res; 2015 Feb; 61():81-8. PubMed ID: 25498133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between brain-derived neurotrophic factor Val66Met polymorphism and body mass index change over time in healthy adults.
    Nikolac Perkovic M; Mustapic M; Pavlovic M; Uzun S; Kozumplik O; Barisic I; Muck-Seler D; Pivac N
    Neurosci Lett; 2013 Jun; 545():127-31. PubMed ID: 23643991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protective effect of the BDNF Met/Met genotype in obesity in healthy Caucasian subjects but not in patients with coronary heart disease.
    Sustar A; Nikolac Perkovic M; Nedic Erjavec G; Svob Strac D; Pivac N
    Eur Rev Med Pharmacol Sci; 2016 Aug; 20(16):3417-26. PubMed ID: 27608901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of bipolar disorder: focus on BDNF Val66Met polymorphism.
    Fan J; Sklar P
    Novartis Found Symp; 2008; 289():60-72; discussion 72-3, 87-93. PubMed ID: 18497095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism with early-onset bipolar disorder.
    Nassan M; Croarkin PE; Luby JL; Veldic M; Joshi PT; McElroy SL; Post RM; Walkup JT; Cercy K; Geske JR; Wagner KD; Cuellar-Barboza AB; Casuto L; Lavebratt C; Schalling M; Jensen PS; Biernacka JM; Frye MA
    Bipolar Disord; 2015 Sep; 17(6):645-52. PubMed ID: 26528762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis.
    Harrisberger F; Smieskova R; Schmidt A; Lenz C; Walter A; Wittfeld K; Grabe HJ; Lang UE; Fusar-Poli P; Borgwardt S
    Neurosci Biobehav Rev; 2015 Aug; 55():107-18. PubMed ID: 25956254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.